The result is better decisions from bench to bedside, and precision therapies reaching patients faster with scientific and clinical confidence.

#ComputationalReasoning #ClinicalValidation #GenomateHealth

#ESMO2025 made one thing clear: oncology is shifting from empirical decision-making to a molecularly defined, data-driven discipline.

#ComputationalReasoning #ClinicalValidation #GenomateHealth

Teach Me in 10: Future of Molecular Diagnostics New for 2025, this event will cover the innovative technologies driving this field, including next-generation sequencing, liquid biopsy, AI-driven diagnostic tools and their integration into clinical ...

Can precision oncology truly be equitable?
Istvan Petak MD, PhD, founder and CSO of Genomate Health, is answering that question in today’s Teach Me in 10 from Technology Networks.

Join the event here: www.technologynetworks.com/tn/online-ev...

#TeachMeIn10 #PrecisionOncology #GenomateHealth